BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
13 results:

  • 1. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
    Jiang Z; Wang H; Wang S; Guan C; Qu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children.
    Wu KS; Jian TY; Sung SY; Hsieh CL; Huang MH; Fang CL; Wong TT; Lin YL
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563678
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS).
    Velaer K; Thomas IC; Yang J; Kapphahn K; Metzner TJ; Golla A; Hoerner CR; Fan AC; Master V; Chertow GM; Brooks JD; Patel CJ; Desai M; Leppert JT
    Urol Oncol; 2022 Jan; 40(1):12.e23-12.e30. PubMed ID: 34580027
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Low KIBRA Expression Is Associated with Poor prognosis in Patients with Triple-Negative Breast Cancer.
    Kim SW; Chu J; Do SI; Na K
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441043
    [No Abstract]    [Full Text] [Related]  

  • 7. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
    Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
    Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma.
    Santos VE; da Costa WH; Bezerra SM; da Cunha IW; Nobre JQC; Brazão ES; Meduna RR; Rocha MM; Fornazieri L; Zequi SC
    Clin Genitourin Cancer; 2021 Aug; 19(4):339-345. PubMed ID: 33839039
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
    Ahn T; Roberts MJ; Abduljabar A; Joshi A; Perera M; Rhee H; Wood S; Vela I
    Mol Imaging Biol; 2019 Oct; 21(5):799-807. PubMed ID: 30617728
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model.
    Chrom P; Stec R; Bodnar L; Szczylik C
    Cancer Res Treat; 2018 Jan; 50(1):103-110. PubMed ID: 28253564
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis.
    Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Perez JR; Agarwal N; Vogelzang NJ
    Clin Genitourin Cancer; 2017 Aug; 15(4):e573-e582. PubMed ID: 28139444
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
    Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.